Adona Medical, a Los Gatos, CA-based Shifamed portfolio company that aims to deliver solutions for heart failure, raised $33.5M in Series C funding.
The round was led by Cormorant Asset Management and TCP Health Ventures, with participation from Excelestar Ventures, the PA MedTech VC Fund II, Unorthodox Ventures, AMED Ventures, and other new and existing investors.
The company intends to use the funds to further enhance its product development and to initiate clinical use of its adjustable interatrial shunt with integrated bi-atrial pressure monitoring.
Led by CEO Brian Fahey, Adona Medical is a pre-clinical stage medical technology company developing interatrial shunting and remote patient monitoring solutions for patients with advanced heart failure. Its heart failure management platform is an investigational device and is not approved for use in the U.S. or anywhere in the world.
FinSMEs
10/07/2024